Literature DB >> 15741102

1H NMR study of inclusion compounds of phenylurea derivatives in beta-cyclodextrin.

N Dupuy1, D Barbry, M Bria, S Marquis, L Vrielynck, J Kister.   

Abstract

Proton nuclear magnetic resonance spectroscopy ((1)H NMR), which has become an important tool for the study "in situ" of beta-cyclodextrin (beta-CD) complexes, was used to study and structurally characterize the inclusion complexes formed between beta-CD and isoproturon, fenuron, monuron and diuron. The high variation of the chemical shifts from the proton located inside the cavity (H-3, H-5 and H-6) coupled with the non variation of the one located outer sphere of the beta-CD (H-1, H-2 and H-4) provided clear evidence of the inclusion phenomena. Two-dimensional rotating frame Overhauser effect spectroscopy (ROESY) experiments were carried out to further support the proposed inclusion mode.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741102     DOI: 10.1016/j.saa.2004.04.031

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.

Authors:  Ana Figueiras; J M G Sarraguça; Rui A Carvalho; A A C C Pais; Francisco J B Veiga
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

2.  Assessment of phenanthrene bioavailability in aged and unaged soils by mild extraction.

Authors:  Muhammad Imran Khan; Sardar Alam Cheema; Chaofeng Shen; Congkai Zhang; Xianjin Tang; Jiyan Shi; Xincai Chen; Joonhong Park; Yingxu Chen
Journal:  Environ Monit Assess       Date:  2011-08-26       Impact factor: 2.513

3.  Novel 1-indanone Thiosemicarbazone Antiviral Candidates: Aqueous Solubilization and Physical Stabilization by Means of Cyclodextrins.

Authors:  Romina J Glisoni; Diego A Chiappetta; Albertina G Moglioni; Alejandro Sosnik
Journal:  Pharm Res       Date:  2011-10-06       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.